Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric O Long

Showing results (11-20 of 91) with videos related to

Pageof 10
Sort By:
The Journal of Experimental Medicine|January 8, 2003
Natural killer cell inhibitory receptors block actin cytoskeleton-dependent recruitment of 2B4 (CD244) to lipid raftsCarsten Watzl, Eric O Long
Nature|November 16, 2018
Cell atlas reveals the landscape of early pregnancySumati Rajagopalan, Eric O Long
Methods in Molecular Biology (Clifton, N.J.)|March 28, 2022
CRISPR Screen to Identify Factors that Render Tumor Cells Sensitive or Resistant to Killing by NK CellsXiaoxuan Zhuang, Eric O Long
Proceedings of the National Academy of Sciences of the United States of America|June 11, 2010
Antagonizing inhibition gets NK cells goingSumati Rajagopalan, Eric O Long
Journal of Immunology (Baltimore, Md. : 1950)|June 11, 2002
KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potentialMathias Faure, Eric O Long
Frontiers in Immunology|August 31, 2012
KIR2DL4 (CD158d): An activation receptor for HLA-GSumati Rajagopalan, Eric O Long
Trends in Immunology|June 28, 2005
Viral evasion of NK-cell activationSumati Rajagopalan, Eric O Long
Proceedings of the National Academy of Sciences of the United States of America|November 28, 2012
Cellular senescence induced by CD158d reprograms natural killer cells to promote vascular remodelingSumati Rajagopalan, Eric O Long
Blood|October 26, 2013
Found: a cellular activating ligand for NKp44Sumati Rajagopalan, Eric O Long
Current Protocols in Immunology|September 4, 2010
Signal transduction during activation and inhibition of natural killer cellsCarsten Watzl, Eric O Long
Pageof 10

Showing results (11-20 of 91) with videos related to

Sort By:
Pageof 10
The Journal of Experimental Medicine|January 8, 2003
Natural killer cell inhibitory receptors block actin cytoskeleton-dependent recruitment of 2B4 (CD244) to lipid raftsCarsten Watzl, Eric O Long
Nature|November 16, 2018
Cell atlas reveals the landscape of early pregnancySumati Rajagopalan, Eric O Long
Methods in Molecular Biology (Clifton, N.J.)|March 28, 2022
CRISPR Screen to Identify Factors that Render Tumor Cells Sensitive or Resistant to Killing by NK CellsXiaoxuan Zhuang, Eric O Long
Proceedings of the National Academy of Sciences of the United States of America|June 11, 2010
Antagonizing inhibition gets NK cells goingSumati Rajagopalan, Eric O Long
Journal of Immunology (Baltimore, Md. : 1950)|June 11, 2002
KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potentialMathias Faure, Eric O Long
Frontiers in Immunology|August 31, 2012
KIR2DL4 (CD158d): An activation receptor for HLA-GSumati Rajagopalan, Eric O Long
Trends in Immunology|June 28, 2005
Viral evasion of NK-cell activationSumati Rajagopalan, Eric O Long
Proceedings of the National Academy of Sciences of the United States of America|November 28, 2012
Cellular senescence induced by CD158d reprograms natural killer cells to promote vascular remodelingSumati Rajagopalan, Eric O Long
Blood|October 26, 2013
Found: a cellular activating ligand for NKp44Sumati Rajagopalan, Eric O Long
Current Protocols in Immunology|September 4, 2010
Signal transduction during activation and inhibition of natural killer cellsCarsten Watzl, Eric O Long
Pageof 10